药械指南

订阅

MedSci主页 / 所有栏目 / 药械指南

抗肿瘤药物临床应用管理办法(试行)

2020-12-22 中华人民共和国国家卫生健康委员会 卫健委

肿瘤

为加强医疗机构抗肿瘤药物临床应用管理，提高抗肿瘤药物临床应用水平，保障医疗质量和医疗安全，国家卫生健康委组织制定了《抗肿瘤药物临床应用管理办法（试行）》（可在国家卫生健康委网站医政医管栏目下载）。现印

中文标题：

抗肿瘤药物临床应用管理办法(试行)

发布机构：

中华人民共和国国家卫生健康委员会

发布日期：

2020-12-22

简要介绍：

为加强医疗机构抗肿瘤药物临床应用管理，提高抗肿瘤药物临床应用水平，保障医疗质量和医疗安全，国家卫生健康委组织制定了《抗肿瘤药物临床应用管理办法（试行）》（可在国家卫生健康委网站医政医管栏目下载）。现印发给你们，请遵照执行。

        

国家卫生健康委

2020年12月22日

相关资料下载：
[AttachmentFileName(sort=1, fileName=抗肿瘤药物临床应用管理办法.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7727d1c002032ad5, title=抗肿瘤药物临床应用管理办法(试行), enTitle=, guiderFrom=卫健委, authorId=0, author=, summary=为加强医疗机构抗肿瘤药物临床应用管理，提高抗肿瘤药物临床应用水平，保障医疗质量和医疗安全，国家卫生健康委组织制定了《抗肿瘤药物临床应用管理办法（试行）》（可在国家卫生健康委网站医政医管栏目下载）。现印, cover=, journalId=0, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Tue Dec 22 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p class="15" style="color: #484848;">为加强医疗机构抗肿瘤药物临床应用管理，提高抗肿瘤药物临床应用水平，保障医疗质量和医疗安全，国家卫生健康委组织制定了《抗肿瘤药物临床应用管理办法（试行）》（可在国家卫生健康委网站医政医管栏目下载）。现印发给你们，请遵照执行。</p> <p class="15" style="color: #484848;">&ensp;&ensp;&ensp;&ensp;&ensp;&ensp;&ensp;&ensp;</p> <p class="15" style="color: #484848;">国家卫生健康委</p> <p class="15" style="color: #484848;">2020年12月22日</p>, tagList=[TagDto(tagId=119, tagName=肿瘤)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=22310, appHits=147, showAppHits=0, pcHits=4671, showPcHits=22163, likes=0, shares=17, comments=8, approvalStatus=1, publishedTime=Wed Dec 30 15:37:35 CST 2020, publishedTimeString=2020-12-22, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=fbzhang, createdTime=Wed Dec 30 15:37:20 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 21:48:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=抗肿瘤药物临床应用管理办法.pdf)])
抗肿瘤药物临床应用管理办法.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1059527, encodeId=3ab3105952ef4, content=很好，实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b65631892, createdName=ms1000000760183413, createdTime=Mon Oct 11 17:23:12 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012539, encodeId=18d3101253926, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa35588095, createdName=影音阁, createdTime=Sun Aug 29 12:23:12 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008499, encodeId=a303100849912, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>进一步促进抗肿瘤药物合理使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76d5574940, createdName=ms8000001223468812, createdTime=Mon Aug 16 23:24:41 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008498, encodeId=ba801008498df, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76d5574940, createdName=ms8000001223468812, createdTime=Mon Aug 16 23:24:10 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956852, encodeId=5597956852d8, content=学习使人进步, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/12/7686683509d4ba42190b214862c10f95.jpg, createdBy=66ed2462809, createdName=巴拉巴拉卡拉卡拉啦啦啦, createdTime=Wed Apr 14 11:17:48 CST 2021, time=2021-04-14, status=1, ipAttribution=)]
    2021-10-11 ms1000000760183413

    很好，实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1059527, encodeId=3ab3105952ef4, content=很好，实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b65631892, createdName=ms1000000760183413, createdTime=Mon Oct 11 17:23:12 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012539, encodeId=18d3101253926, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa35588095, createdName=影音阁, createdTime=Sun Aug 29 12:23:12 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008499, encodeId=a303100849912, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>进一步促进抗肿瘤药物合理使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76d5574940, createdName=ms8000001223468812, createdTime=Mon Aug 16 23:24:41 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008498, encodeId=ba801008498df, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76d5574940, createdName=ms8000001223468812, createdTime=Mon Aug 16 23:24:10 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956852, encodeId=5597956852d8, content=学习使人进步, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/12/7686683509d4ba42190b214862c10f95.jpg, createdBy=66ed2462809, createdName=巴拉巴拉卡拉卡拉啦啦啦, createdTime=Wed Apr 14 11:17:48 CST 2021, time=2021-04-14, status=1, ipAttribution=)]
    2021-08-29 影音阁

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1059527, encodeId=3ab3105952ef4, content=很好，实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b65631892, createdName=ms1000000760183413, createdTime=Mon Oct 11 17:23:12 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012539, encodeId=18d3101253926, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa35588095, createdName=影音阁, createdTime=Sun Aug 29 12:23:12 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008499, encodeId=a303100849912, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>进一步促进抗肿瘤药物合理使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76d5574940, createdName=ms8000001223468812, createdTime=Mon Aug 16 23:24:41 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008498, encodeId=ba801008498df, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76d5574940, createdName=ms8000001223468812, createdTime=Mon Aug 16 23:24:10 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956852, encodeId=5597956852d8, content=学习使人进步, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/12/7686683509d4ba42190b214862c10f95.jpg, createdBy=66ed2462809, createdName=巴拉巴拉卡拉卡拉啦啦啦, createdTime=Wed Apr 14 11:17:48 CST 2021, time=2021-04-14, status=1, ipAttribution=)]
    2021-08-16 ms8000001223468812

    #肿瘤#进一步促进抗肿瘤药物合理使用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1059527, encodeId=3ab3105952ef4, content=很好，实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b65631892, createdName=ms1000000760183413, createdTime=Mon Oct 11 17:23:12 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012539, encodeId=18d3101253926, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa35588095, createdName=影音阁, createdTime=Sun Aug 29 12:23:12 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008499, encodeId=a303100849912, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>进一步促进抗肿瘤药物合理使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76d5574940, createdName=ms8000001223468812, createdTime=Mon Aug 16 23:24:41 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008498, encodeId=ba801008498df, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76d5574940, createdName=ms8000001223468812, createdTime=Mon Aug 16 23:24:10 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956852, encodeId=5597956852d8, content=学习使人进步, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/12/7686683509d4ba42190b214862c10f95.jpg, createdBy=66ed2462809, createdName=巴拉巴拉卡拉卡拉啦啦啦, createdTime=Wed Apr 14 11:17:48 CST 2021, time=2021-04-14, status=1, ipAttribution=)]
    2021-08-16 ms8000001223468812

    很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1059527, encodeId=3ab3105952ef4, content=很好，实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b65631892, createdName=ms1000000760183413, createdTime=Mon Oct 11 17:23:12 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012539, encodeId=18d3101253926, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa35588095, createdName=影音阁, createdTime=Sun Aug 29 12:23:12 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008499, encodeId=a303100849912, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>进一步促进抗肿瘤药物合理使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76d5574940, createdName=ms8000001223468812, createdTime=Mon Aug 16 23:24:41 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008498, encodeId=ba801008498df, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76d5574940, createdName=ms8000001223468812, createdTime=Mon Aug 16 23:24:10 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956852, encodeId=5597956852d8, content=学习使人进步, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/12/7686683509d4ba42190b214862c10f95.jpg, createdBy=66ed2462809, createdName=巴拉巴拉卡拉卡拉啦啦啦, createdTime=Wed Apr 14 11:17:48 CST 2021, time=2021-04-14, status=1, ipAttribution=)]
    2021-04-14 巴拉巴拉卡拉卡拉啦啦啦

    学习使人进步

    0

相关指南

主方案：有效临床设计策略以拓展肿瘤药物和生物制品的开发（草案）

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2018-10-03

FDA成人肿瘤临床试验纳入青少年患者的共识

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2019-09-02

中国女性肿瘤患者生育力保护及保存专家共识

中国肿瘤科相关专家小组（统称） · 2020-05-20

新型抗肿瘤药物临床应用指导原则（2019年版）

中华人民共和国国家卫生健康委员会 · 2019-12-21

已上市抗肿瘤药物增加新适应症技术指导原则

国家药品监督管理局药品审评中心（CDE） · 2019-10-31

抗肿瘤药物临床试验技术指导原则

国家药品监督管理局药品审评中心（CDE） · 2012-05-15